Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Streptokinase After Primary PCI in AMI
NCT00302419Phase 4Completed
- Sponsor
- Istanbul University
- Start
- Oct 2004
- Primary completion
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of streptokinase in acute myocardial infarction (AMI) (2 arms), sponsored by Istanbul University. Primary endpoints: Indices of Microvascular Perfusion at 48 hours, Left Ventricular Infarct Size at 6 months and 2 more. Started Oct 2004; status: completed.
02
Drugs
streptokinase
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00302419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302419.